¤E¤Q¦~«×¤º¬ì±M¬ìÂå®v¦Ò¸Õµ§¸ÕÃD -- ¦Ò¥jÃD

(B) 1. ÀVÀR¯ß«ã±i¤§¯fºA¡A¥i¦b¦óºØ¯e¯f¥X²{¡G (1) ¤T¦y䳬Âꤣ¥þ¡C (2) ¤ßÁY©Ê¤ß¥]½¤ª¢¡]constrictive pericarditis¡^¡C (3) ¥D°Ê¯ß䳬Âꤣ¥þ¡C (4) ÂX¤j©Ê¤ß¦Ù¯g¡C
A.1+2+3
B.1+2+4
C.1+3
D.1+3+4
E.2+3+4
 
(C) 2. ¨Ï¥Î«D«I¥Ç©Ê©I§lªvÀø¡]Noninvasive ventilation¡^ªº¾AÀ³¯g¡A¤U¦C¦óªÌ°£¥~¡H
A.°Ê¯ß¦åpH > 7.22¡C
B.¤ßŦ´`Àô¥\¯àí©w¡C
C.©I§l¹D¤Àªcª«¹L¦h¡C
D.µL¤W©I§l¹Dªý¶ë¯fÅÜ¡C
E.¯«´¼²M·¡¡B¦X§@ªº¯f¤H¡C
 
(D) 3. ¦³Ãö¶Ý»Ì²Ó­M½F¤§±Ô­z¡A¦óªÌ¦³»~¡H (1) §¿catecholamine¤§´ú©w¤ñmetanephrine¡BVMA´ú©w¶EÂ_²v°ª¡C (2) paroxysmal°ª¦åÀ£¤ñ«ùÄò©Ê°ª¦åÀ£±`¨£¡C (3) ³N«á§C¦åÀ£¥i¥Î£\-ªýÂ_¾¯©ó³N«e¨Ï¥Î¨Ó¹w¨¾¡C (4) ©óMEN¯g­Ô¸s®É¡AÀ³¥ý¤Á°£¶Ý»Ì²Ó­M½F¡C (5) ²Ó°w¬ï¨ë²Ó­M¾Ç¥i¥Î¨ÓŲ§O¶EÂ_¡C
A.1+3
B.2+4
C.3+5
D.2+5
E.1+4
 
(D) 4. ¥þ¨­©Ê¬õ´³©Ê¯T½H(SLE)®É¡A¦³¦óºØ²Õ¦X¡A»Ý­n°ª¾¯¶qÃþ©T¾J©Î¨ä¥L±j¤OªºªvÀø¡H
A.Fever and arthritis
B.Pleurisy and Raynaud's phenomenon
C.Peripheral neuropathy and skin vasculitis
D.Central nervous system disease and hemolytic anemia (marked)
E.Skin vasculitis and splenomegaly
 
(A) 5. ¹ï©ó­¹¹DÀR¯ß¦±±i¥X¦åªº±wªÌ¡A¤U¦C¦UºØªvÀø¤è¦¡¡A¦óªÌ¿ù»~¡H
A.«æ©Ê¥X¦å®É¡A¥i¦Ò¼{¨Ï¥ÎH2-receptor blocker¡C
B.«æ©Ê¥X¦å®É¡A¥i¦Ò¼{¨Ï¥ÎVasopressin©Î¨ä­l¥Íª«¡C
C.«æ©Ê¥X¦å®É¡A¥i¦Ò¼{¬I¥HEndoscopic sclerotherapy©Îligation¡C
D.±¡ªpí©w«á¡A¥i¦Ò¼{¨Ï¥Îpropranololµ¥«D¿ï¾Ü©Ê£]-adrenergic blocker¨Ó¹w¨¾¨ä¦A¥X¦å¡C
E.¤@¦A¥X¦åªÌ¡A¥i¦Ò¼{¨Ï¥ÎTIPS¡]Transjugular Intrahepatic Portosystemic Shunting¡A¤@ºØ¥´³q¨xÀR¯ß©M¨xªù¯ß¤§§Þ³N¡^¡C
 
(B) 6. ¤U¦C¨º¤@­Ó°ò¦](gene)»P²Ó­M­ä¤`(apoptosis)¦³Ãö¡H
A.Bcl-1
B.Bcl-2
C.Bcl-6
D.c-myc
E.ras-gene
 
(D) 7. ¤U¦C¦³Ãö¨ÅÁÞúC¯Ê¥F¯g¡]lactase deficiency¡^¤§±Ô­z¡A¦óªÌ¥¿½T¡H (1) ±wªÌÁT«K¤§pH­È±`¸û§C (2) ¯gª¬±`¶}©l©ó¥®¦~´Á (3) ¥Õ¤H¤§¿©±w²v¤Ö©ó¶Â¤H¤ÎªF¤è¤H (4) ¨ÅÁÞ©I§l²B§t¶q´ú©w¦³§U¶EÂ_ (5) ¹ïÀu¹T¨Å¡]yogurt¡^¥ç¤£¯à§Ô¨ü
A.1+2+3+4
B.2+3+4+5
C.1+3+4+5
D.1+3+4
E.2+3+4
 
(B) 8. ¥Ö½§¤W§e²{·L¦åºÞÂX±i(telangiectasia)¡A±`»P¨ä¥¦¯e¯f¦³Ãö¡A¦pªG¬O¦b«ü¥Ò©P³ò¡A«h¤U¦C¦óªÌ¥¿½T¡H (1) Cirrhosis(¨xµw¤Æ) (2) Dermatomyositis(¥Ö¦Ùª¢) (3) Lupus erythematosus(¬õ´³©Ê¯T½H) (4) Scleroderma(µw¥Ö¯g) (5) Tuberculoid leprosy(µ²®Ö«¬³ÂºÆ)
A.1+2+5
B.2+3+4
C.3+4
D.2+3+5
E.1+5
 
(D) 9. ºë¯«¯«¸g§K¬Ì¾Ç¡]Psychoneuroimmunology¡^¬O¬ã¨sÀ£¤O»P§K¬ÌÃö«Yªº·s¿³¬ì¾Ç¡Aºî¦X¹L¥hªº¬ã¨sµo²{¡A¤U¦C¨º¶µ±Ô­z¬°¥¿½T¡H
A.§K¬Ì¥\¯à¤£¨ü¶Ê¯v¼vÅT
B.²O¤Ú²y¤£·|¤Àªc¯«¸g¶Ç¾Éª«½è¡]neurotransmitters¡^
C.¥Íªø¿E¯À¡]growth hormone¡^¤£·|¼vÅT§K¬Ì¤O
D.³z¹L¨î¬ù¡]conditioning¡^¥i¼vÅT§K¬Ì¨t²Î¥\¯à
E.ÃĪ«ÀݥΦp°sºë»P¥§¥j¤B¨Ã¤£·|¼vÅT§K¬Ì¨t²Î¥\¯à
 
(D) 10. ¤@¦ì66·³¨k©Ê¯f¤HÁy³¡¡BÀV³¡¤Î­I³¡¦³¬õ´³¡A¦h¼ÆÃö¸`»Äµh¡A¥|ªÏªºªñºÝ¦Ù¦×µL¤O¡A¦³¤G¬P´Á¤§¤[¡C¸g©â¦åÀˬdµo²{CPK (MM type)¡AGPT¤Îaldolase§¡¦³©úÅã¼W¥[¡A¶EÂ_¬°dermatomyositis¡C¸Õ°Ý³o­Ó¯f¤HÁÙ¥²¶·±µ¨ü¨ÇÀˬd¡H
A.¥Ö½§ªº¯f²zÀˬd
B.¦Ù¦×¤Î¯«¸g¾ÇÀˬd
C.§K¬Ì¦å²M¾ÇÀˬd
D.¸~½Fªº¿zÀË
E.¤ßªÍ¥\¯àªºÀˬd
 
(B) 11. ¦³¤@40·³¨k©Ê³ÌªñÅé­«¼W¥[¡]5¤½¤ç/2¤ë¡^¡A¤â¦³³Â¤ì·P¡A®É±`·Pı­Â«å¡B¦h¦½¡A²z¾ÇÀˬd²{BP 146/94 mmHg¡APR 72/min¡Aregular¡AÁy³¡ªo¥ú¡A¦³carpal tunnel syndrome¡A¸g¸ß°Ý¯f¤Hµo²{¾c¤l¸¹¼ÆÅܤj¡C¿ï¤@³Ì¾A·í¤§µª®×¡G
A.¯f¤H¦³dysmetabolic syndrome X
B.¯f¤Hªº¤â³Â¤ì¬O¦]ªÏºÝ³n²Õ´À£­¢©Ò­P
C.°ò¦¥Íªø¿E¯À´ú©w¥iŲ§O¶EÂ_
D.µ¹¤©¯f¤HL-Dopa¡A¥Íªø¿E¯À¦å¼ß¿@«×À³¤É°ª
E.Octreotide (Sandostatin)ªºªvÀø§K°£¤Ftrans-sphenoid surgery
 
(D) 12. ¦³ÃöºKµÊ¡]splenectomy¡^¡A¤U¦C¨º¤@¶µ±Ô­z¬O¿ù»~ªº¡H
A.¥Î©óªvÀø¥ý¤Ñ©Ê²yª¬¬õ¦å²y¯g¡]congenital spherocytosis¡^
B.¥Î©óªvÀøµÊ¤®¶i¡]hypersplenism¡^©Ò¾É­P¤§¦å²y´î¤Ö¯g¡]cytopenia¡^
C.¥Î©óªvÀø¾vª¬²Ó­M©Ê¥Õ¦å¯g¡]hairy cell leukemia¡^
D.ºKµÊ«á¡A±`¨£WBC¼Æ¼W¥[¡A¦ý¬õ¦å²y§ÎºA«h¨S¦³ÅܤÆ
E.20·³¥H¤U±wªÌ¡AºKµÊ«á¡A¸û©ö¦³ÄY­«²Óµß·P¬V
 


< ¤E¤Q¦~«×¸ÕÃD¥Ø¿ý >